News

Senhwa Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to CX-4945 for the treatment of cholangiocarcinoma. CX-4945 is…
Read More...

Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immuno-therapeutic products and vaccines, today…
Read More...

Körber AG completed the acquisition of the US-American Fargo Automation Inc. with effect from January 3, 2017. Fargo Automation’s pharmaceutical packaging equipment ‑ which include…
Read More...

Dermira, Inc., a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of patients with…
Read More...

Marinus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced that…
Read More...

Sharp Edge Labs, Inc., a drug discovery and development company focused on diseases involving defective protein trafficking, today announced that it has entered into a drug discovery…
Read More...

Drug firm Lupin has received final approval from the US health regulator to market cevimeline hydrochloride capsules, used for treatment of symptoms of dry mouth in patients with…
Read More...

Suven Life Sciences Ltd announces that the grant of one (1) product patent from Eurasia (025136) and one (1) product patent from Norway (339034) corresponding to the New Chemical…
Read More...

Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co. Inc., in the United States and…
Read More...

Ligand Pharmaceuticals announces it has entered into global license and supply agreements with Novartis for the development and commercialization of a Captisol-enabled oral liquid…
Read More...

Swiss company Genticel and Genkyotex have signed an agreement to enter into strategic combination. A portfolio of NADPH oxidase (NOX) oral small molecule inhibitors are being…
Read More...

Novo Nordisk has awarded Fluor an engineering, procurement, construction and construction management contract for its new $2bn diabetes Active Pharmaceutical Ingredient (API)…
Read More...

uniQure announced that its Board of Directors has unanimously approved the appointment of Matthew Kapusta as Chief Executive Officer (CEO) of the Company, effective immediately. Mr.…
Read More...

A jury in the US District Court for the District of Delaware ordered Gilead Sciences to pay $2.54bn in damages to Merck's subsidiary Idenix Pharmaceuticals for infringing its patents in…
Read More...

GSK is opening a new global vaccines research and development (R&D) center in Rockville, Maryland, US. Up to 200 new jobs will be created at the Rockville facility, with GSK…
Read More...

US drug developer Alexion Pharmaceuticals has named David Brennan as interim CEO, effective immediately. Brennan is the former Chief Executive Officer and Executive Director of…
Read More...

West Pharmaceutical Services has completed a 60,000ft² expansion at its contract manufacturing facility near Mulhuddart, County Dublin, Ireland. The expansion is in response to…
Read More...

Patheon, a global provider of pharmaceutical development and manufacturing services, has agreed to acquire an active pharmaceutical ingredients (API) manufacturing facility in Florence,…
Read More...

Menarini-Silicon Biosystems said its DEPArray single-cell isolation technology played an important role in a study carried out by researchers from The University of Manchester to…
Read More...

Neovacs has partnered with 3P Biopharmaceuticals to manufacture interferon alpha (IFNα) cytokine. The collaboration follows the recent acquisition of the technology for the…
Read More...